The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines

BACKGROUND: Subsidised access to high-cost medicines in Australia is restricted under national programs (the Pharmaceutical Benefits Scheme, PBS, and the Repatriation Pharmaceutical Benefits Scheme, RPBS) with a view to achieving cost-effective use. The aim of this study was to examine the use and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Christine Y, Williams, Kenneth M, Day, Richard O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828161/
https://www.ncbi.nlm.nih.gov/pubmed/17331230
http://dx.doi.org/10.1186/1743-8462-4-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828161/
https://www.ncbi.nlm.nih.gov/pubmed/17331230
http://dx.doi.org/10.1186/1743-8462-4-2

Ejemplares similares